Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,099 | 546 | 97.6% |
| Education | $199.41 | 21 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,382 | 125 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $870.40 | 55 | $0 (2024) |
| ABBVIE INC. | $560.24 | 31 | $0 (2024) |
| Alkermes, Inc. | $541.39 | 35 | $0 (2024) |
| Lundbeck LLC | $478.67 | 28 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $478.67 | 40 | $0 (2024) |
| ITI, Inc. | $432.00 | 25 | $0 (2023) |
| Allergan, Inc. | $383.00 | 36 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $373.60 | 23 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $370.67 | 26 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,613 | 91 | Otsuka America Pharmaceutical, Inc. ($229.83) |
| 2023 | $1,599 | 89 | ABBVIE INC. ($248.42) |
| 2022 | $1,244 | 74 | Sunovion Pharmaceuticals Inc. ($218.46) |
| 2021 | $533.26 | 35 | AbbVie Inc. ($152.18) |
| 2020 | $572.22 | 41 | Otsuka America Pharmaceutical, Inc. ($155.40) |
| 2019 | $1,042 | 80 | Janssen Pharmaceuticals, Inc ($336.90) |
| 2018 | $849.95 | 75 | Otsuka America Pharmaceutical, Inc. ($196.37) |
| 2017 | $845.55 | 82 | Otsuka America Pharmaceutical, Inc. ($203.81) |
All Payment Transactions
567 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $15.64 | General |
| Category: Psychiatry/Psychology | ||||||
| 12/11/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $34.98 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: CNS | ||||||
| 11/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $2.49 | General |
| Category: CNS | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $0.35 | General |
| Category: PSYCHIATRY | ||||||
| 11/04/2024 | Janssen Pharmaceuticals, Inc | INVEGA SUSTENNA (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Neuroscience | ||||||
| 10/31/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $21.30 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/29/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: CNS | ||||||
| 10/28/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PSYCHIATRY | ||||||
| 10/21/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: SCHIZOPHRENIA | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/10/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.29 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 09/25/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $24.68 | General |
| Category: PSYCHIATRY | ||||||
| 09/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: Neuropsychiatry | ||||||
| 09/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $2.31 | General |
| Category: Neuropsychiatry | ||||||
| 09/19/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Central Nervous System | ||||||
| 09/18/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $126.24 | General |
| 09/18/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2024 | Noven Therapeutics, LLC | Xelstrym (Drug), Secuado | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: ADHD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 607 | 1,232 | $218,485 | $76,856 |
| 2022 | 13 | 795 | 1,496 | $259,725 | $92,420 |
| 2021 | 10 | 858 | 1,645 | $289,180 | $107,468 |
| 2020 | 10 | 957 | 1,665 | $270,320 | $84,519 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2023 | 114 | 118 | $42,000 | $15,178 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 154 | $34,060 | $13,574 | 39.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 110 | 233 | $35,015 | $12,735 | 36.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 82 | 164 | $24,600 | $9,839 | 40.0% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 97 | 232 | $25,520 | $8,656 | 33.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 46 | 166 | $23,240 | $7,895 | 34.0% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 32 | 105 | $19,900 | $4,354 | 21.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 23 | $8,600 | $3,095 | 36.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 20 | 25 | $3,750 | $840.82 | 22.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 12 | 12 | $1,800 | $688.38 | 38.2% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2022 | 124 | 126 | $44,350 | $16,449 | 37.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 78 | 152 | $33,440 | $13,177 | 39.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 113 | 219 | $32,850 | $12,024 | 36.6% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 150 | 347 | $38,170 | $10,231 | 26.8% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 48 | 209 | $29,335 | $9,962 | 34.0% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 77 | 131 | $19,650 | $7,055 | 35.9% |
| 99335 | Established patient custodial care facility, group care, or assisted living visit, typically 25 minutes | Office | 2022 | 26 | 79 | $14,970 | $5,294 | 35.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 33 | $11,680 | $5,048 | 43.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 52 | 69 | $10,350 | $3,861 | 37.3% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2022 | 18 | 26 | $5,720 | $2,457 | 43.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2022 | 16 | 16 | $6,400 | $2,439 | 38.1% |
| 99334 | Established patient custodial care facility, group care, or assisted living visit, typically 15 minutes | Office | 2022 | 24 | 48 | $5,760 | $1,821 | 31.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 24 | 26 | $3,900 | $1,403 | 36.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 15 | $3,150 | $1,199 | 38.0% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Facility | 2021 | 186 | 196 | $68,315 | $26,901 | 39.4% |
About Dr. Chinya Murali, MD
Dr. Chinya Murali, MD is a Psychiatry healthcare provider based in Saint Peters, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831156868.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chinya Murali, MD has received a total of $8,299 in payments from pharmaceutical and medical device companies, with $1,613 received in 2024. These payments were reported across 567 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($8,099).
As a Medicare-enrolled provider, Murali has provided services to 3,217 Medicare beneficiaries, totaling 6,038 services with total Medicare billing of $361,263. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Psychiatry
- Other Specialties Geriatric Psychiatry
- Location Saint Peters, MO
- Active Since 04/26/2006
- Last Updated 01/12/2021
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831156868
Products in Payments
- REXULTI (Drug) $1,272
- VRAYLAR (Drug) $834.53
- CAPLYTA (Drug) $547.55
- ABILIFY MAINTENA (Drug) $540.92
- SPRAVATO (Drug) $519.61
- ARISTADA (Drug) $449.72
- INGREZZA (Drug) $373.60
- LATUDA (Drug) $370.67
- TRINTELLIX (Drug) $324.90
- INVEGA SUSTENNA (Drug) $320.61
- BELSOMRA (Drug) $211.35
- Trintellix (Drug) $198.14
- NUEDEXTA (Drug) $185.31
- Fanapt (Drug) $152.30
- HETLIOZ (Drug) $139.85
- Auvelity (Drug) $133.54
- QELBREE (Drug) $118.08
- AUSTEDO (Drug) $113.01
- Adzenys XR-ODT (Drug) $98.90
- Dayvigo (Drug) $96.58
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Saint Peters
Satish Kulkarni, Md, MD
Psychiatry — Payments: $19,489
Dr. Roomana Arain, M.d, M.D
Psychiatry — Payments: $3,993
Dr. Raafea Malik, M.d, M.D
Psychiatry — Payments: $2,123
Thripura Thirtala, M.d, M.D
Psychiatry — Payments: $2,057
Srinivas Battula, Md, MD
Psychiatry — Payments: $718.20
Dawn Holemon, M.d, M.D
Psychiatry — Payments: $191.24